Member Info for bigAl67

4 Million Shares Traded in 2 hours - 1 Million in the past 30 mIns !!!

Hi Jay,
Yep - Good Post to System - Wish You and All of us Shareholders the Very Best with 'OUR GDR INVESTMENT' !!!

Oh Yes stephen11 - GDR Rocket is 'Ready and Waiting' !!

Still in simmering mode at the Mo - just a 200% rise in the past Month !!! LOL
Top Quality fuel Topped up too !!! LOL

You were right System :-
Open
25.81
High
30.00
Low
25.25

Agreed stephen11,
Anything is possible while a rise like this 'Is Happenning' !!! - without an RNS !!

Come On You GDR !! :-

Market Summary >
Genedrive PLC
26.80 GBX
+17.30 (182.11%)past month
27 Jan, 09:17 GMT • Disclaimer

LOL - So James is Right - QED !!

Hi Jay,

Yesterday you did actually say:- 'think we might drop to about 10 percent up today'
jayhayes
Posted in: GDR
Posts: 3,992
Price: 22.25
No Opinion
RE: starting to drop26 Jan 2023 14:20
think we might drop to about 10 percent up today

Hi LTH,

I think James is right - I cannot see anywhere in our SP Chart history where our SP % fall, fell as fast as it is currently rising ?
Up 180% in a month !!

Good morning bigbench,

I still remember the days when your MoJo was still in tact, and you would say:-

It Is 'FOMO Friday'

And 'I would not want to be out of this share over the Week End'

Looking for ward to your MoJo returned !!

Ah thanks for clearing that up ! - GDR looking Good this past month - Long may it continue !!!
Market Summary >
Genedrive PLC
22.22 GBX
+12.72 (133.95%)past month
26 Jan, 15:04 GMT • Disclaimer

bought not nought LOL

I thought you nought back into GDR on the 3rd Jan 2023 Jay ?

jayhayes
Posted in: GDR
Posts: 3,992
Price: 12.50
No Opinion
RE: Creeping Up03 Jan 2023 09:52
Just bought back guys

Yes David Budd did say in our November Presentation that they though feedback from the FDA on our AIHL Pre-Sub sometime around late Jan/early Feb !!

Our SP Up 131% over the past month, and we still have a disparity of 500,000 more shares sold than Bought today, surely this disparity will reduce through further Buying Today ?!!

Market Summary >
Genedrive PLC
21.99 GBX
+12.49 (131.50%)past month
26 Jan, 12:37 GMT • Disclaimer

# Trades 200
Vol. Sold 1,328,779
Sold Value £271,514.27
Vol. Bought 797,302
Bought Value £163,724.15
Open
19.50
High
22.00
Low
19.00
Mkt cap
20.27M

'NICE' Start to our Day !!!
Market Summary >
Genedrive PLC
21.09 GBX
+1.69 (8.70%)today
26 Jan, 08:17 GMT • Disclaimer

It is a Massive pleasure stephen11 !!!

'NICE' SP rise into the close, (pardon the Pun), our SP has not closed at this level since the 12th August 2022 !!
Volume of shares sold were way ahead of Volume Bought when the 335K sell went through, But this sell seemed to trigger a Buying spree, with a 104% SP rise over the past month - This is Not a 'Standard Pump and Dump' as some have called it LOL !!
Decent Volume traded today too at 2,592,558, making a total of 16,546,595 share trades over the past 5 trading days !!
Today marks the 3rd day in a row that our SP has closed higher than the previous days close !! -'NICE' to see !! - Long may this continue !!

Market Summary >
Genedrive PLC
19.40 GBX
+9.90 (104.21%)past month
25 Jan, 17:08 GMT • Disclaimer
Open
17.49
High
20.00
Low
16.30
# Trades 134
Vol. Sold 1,149,421
Sold Value £200,578.96
Vol. Bought 1,360,447
Bought Value £248,484.81
Mkt cap
17.99M

I thought that our Stroke Marker Test (CYP2C ID Kit) is included in the NICE Fast Track (EVA) along with our AIHL Test. However, I now do not believe our Stroke Marker Test is being fast tracked by NICE, but is following the New NICE DAP process.
I have just checked our Final Results RNS dated 21st November 2022, and it states:-

· NICE accelerated evaluation of the Genedrive® MT-RNR1 ID test. - Which is the Early Value Assessment (EVA)

Chairman statement:-
Our Antibiotic Induced Hearing Loss (AIHL) test is the world's first molecular test in an acute point-of-care setting. The test delivers a molecular diagnostic result in under 30 minutes and allows for treatment selection options depending on the genetic variant of the patient. The Genedrive® MT-RNR1-ID Kit is now being fast tracked for assessment in the UK by NICE. This is testimony to the potential of both better health outcomes for patients and positive health economic benefits to the NHS and healthcare systems around the world. I find it hugely rewarding to see our innovations setting new-borns off on a more positive healthcare trajectory than was previously possible.

· NICE includes Genedrive® CYP2C19 ID Kit in Diagnostics Assessment Programme - which is (DAP)

Chief Executives Review:-
I am very positive about our Genedrive® CYP2C19-ID Kit - a simple, rapid point-of-care test in development, with no requirement for user result interpretation and provides results in a clinically actionable timeframe for ischemic stroke patients. Similar to AIHL, it uses our capabilities, chemistry and hardware to rapidly produce a result at an emergency care bedside. By analysing the genes of a patient's drug metabolic pathway, certain poor drug options can be removed from the treatment regimen of each individual patient, with the aim of providing reduced incidence of subsequent strokes and clots, and better clinical outcomes.

A Great finish to the day/week. In fact a Great past month for genuine shareholders !!!

Market Summary >
Genedrive PLC
18.02 GBX
+8.27 (84.87%)past month
20 Jan, 16:55 GMT • Disclaimer